Home/Pipeline/Embryo Culture Optimization Platform

Embryo Culture Optimization Platform

Improvement of In Vitro Fertilization (IVF) Outcomes

Pre-clinicalActive

Key Facts

Indication
Improvement of In Vitro Fertilization (IVF) Outcomes
Phase
Pre-clinical
Status
Active
Company

About dawn-bio

dawn-bio is a private, pre-revenue biotech company based in Vienna, Austria, developing a novel platform for in vitro fertilization (IVF). The company's core technology is a human stem-cell based embryo and implantation model (blastoid technology) that allows for unprecedented research into early human development. Its initial goal is to develop products that enable IVF clinics to improve embryo quality and quantity, addressing the high failure rates in current treatments. The team combines deep scientific expertise in stem cell biology and embryology with seasoned pharmaceutical and biotech entrepreneurship.

View full company profile